PUBLISHER: The Business Research Company | PRODUCT CODE: 1650627
PUBLISHER: The Business Research Company | PRODUCT CODE: 1650627
Microneedle Drug Delivery Systems are sophisticated medical devices that utilize arrays of micron-sized needles to deliver drugs, vaccines, and other therapeutic agents through the skin with minimal invasiveness. They penetrate the stratum corneum without reaching deeper nerve endings, thereby minimizing pain and discomfort.
The main types of technologies used in microneedle drug delivery systems include solid microneedle technology, hollow microneedle technology, dissolved microneedle technology, and others. In the solid microneedle method, peptides are dried onto the tips of a microneedle array, utilizing a coating of potent chemicals. These solid microneedles typically measure between 250 micrometers to 700 micrometers in length and are presented in patch form, allowing for storage at room temperature. Microneedle drug delivery systems find application in drug delivery, vaccine administration, and other therapeutic uses. They are employed in various settings such as diagnostic laboratories, life sciences, research laboratories, hospitals, ambulatory surgical centers, and other medical facilities.
The microneedles drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides microneedle drug delivery systems market statistics, including microneedle drug delivery systems industry global market size, regional shares, competitors with a microneedle drug delivery systems market share, detailed microneedles drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle drug delivery systems industry. This microneedle drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The microneedle drug delivery systems market size has grown rapidly in recent years. It will grow from $5.01 billion in 2024 to $5.9 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to pain-free drug delivery, enhanced patient compliance, chronic disease management, cosmetic and aesthetic applications, vaccine administration.
The microneedle drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $11.44 billion in 2029 at a compound annual growth rate (CAGR) of 18.0%. The growth in the forecast period can be attributed to cosmetic and aesthetic applications, emergingTherapies, pediatric and geriatric use, global health initiatives, point-of-care testing. Major trends in the forecast period include smart microneedles, advancements in material science, advancements in wearable technology, biodegradable materials, continuous glucose monitoring.
The growing research efforts and demand for vaccination are anticipated to drive the growth of the microneedle drug delivery systems market. Researchers see microneedles as an alternative method for vaccine administration, allowing recipients to experience little to no pain. Initially developed for flu and measles vaccines, microneedle patches are now increasingly utilized for the delivery of COVID-19 vaccines as well. For example, in April 2024, the Office for National Statistics, a UK-based government agency, reported that the UK government's net expenditure on research and development (R&D), excluding contributions to the EU R&D budget, rose to $17.01 billion (£15.5 billion) in 2022, up from $15.37 billion (£14.0 billion) in 2021, reflecting a 10.5% increase. Including contributions to the EU R&D budget and knowledge transfer activities, total net expenditure on R&D reached $18.006 billion (£16.4 billion) in 2022, marking an 8.9% increase from $16.46 billion (£15.0 billion) in 2021. Thus, the rise in research and demand for the vaccination process is propelling the microneedle drug delivery systems market moving forward.
The rising prevalence of obesity is expected to drive the growth of the microneedle drug delivery systems market in the future. Obesity is a medical condition defined by an excess of body fat that can adversely affect an individual's health. Microneedle drug delivery systems are utilized for obesity management by providing a convenient and painless method for administering medications to patients. For example, in May 2024, the Office for Health Improvement and Disparities, a UK-based government agency, estimated that 64.0% of adults aged 18 and older in England were either overweight or living with obesity between 2022 and 2023. Of these individuals, 26.2% were classified as living with obesity. The prevalence of being overweight (including obesity) was higher in men (69.2%) than in women (58.6%). However, obesity rates among adults were comparable for both genders, with 26.4% of men and 26.2% of women living with obesity. Therefore, the increasing prevalence of obesity is driving the growth of the microneedle drug delivery systems market.
Major companies in the microneedle drug delivery systems market are concentrating on product innovation, such as radiofrequency microneedle systems, to deliver dependable services to their customers. A radiofrequency microneedle system is a minimally invasive technology that integrates microneedles with radiofrequency energy to improve drug delivery and stimulate collagen production in the skin for both therapeutic and cosmetic purposes. For example, in February 2023, Candela, a US-based medical aesthetic device manufacturer, introduced the Profound Matrix system. This multi-application system includes the Sublime, Sublative RF, and the cutting-edge Matrix Pro applicators. Both the Sublime and Sublative RF utilize bipolar radiofrequency (RF) technology to enhance the appearance of fine lines and wrinkles, while the Matrix Pro applicator is designed to regenerate and stimulate collagen production. It features a series of slender microneedles that deliver short-pulse RF energy to the skin, resulting in improved patient comfort, decreased downtime, and enhanced overall outcomes.
Major companies in the microneedle drug delivery systems market are forming partnerships to boost their profitability. For example, in January 2024, Cynosure, a US-based manufacturer of medical and aesthetic treatment systems, collaborated with LaserAway, a US-based provider of aesthetic dermatology, to expand the availability of the Potenza RF Microneedling technology to all LaserAway locations across the country. This partnership allows LaserAway to offer RF Microneedling to a wider patient demographic throughout the United States. Proponents emphasize that Potenza, a four-mode RF microneedling device, enhances customization options for clinicians and advances the capabilities of RF microneedling technology.
In November 2022, Kindeva Drug Delivery, a US-based drug delivery company, merged with Meridian Medical Technologies. The integration of Kindeva Drug Delivery and Meridian Medical Technologies will emphasize several key technologies, including parenteral drug delivery via autoinjectors, inhalation devices, transdermal delivery systems, and intradermal delivery techniques. Meridian Medical Technologies is a US-based manufacturer specializing in drug delivery systems.
Major companies operating in the microneedle drug delivery systems market include 3M Company, Zosano Pharma Corporation, Becton-Dickinson Technologies, Nanopass Technologies, Corium Inc., Valeritas Inc., Microdermics, TheraJect Inc., LTS Lohmann Therapie-Systeme AG, BioSerenTach (BT), Sorrento Therapeutics, Debiotech, Raphas Co. Ltd., QuadMedicine, Snvia Co. Ltd., NanoBiosciences LLC, AdminMed nanoBioSciences LLC, Nitto Denko Corporation, MyLife Technologies, Innoture Medical Technology Limited, Phillips-Medisize Corporation, Stemedica Cell Technologies Inc., Candela Corporation, Dermaroller GmbH, Micropoint Technologies, Vaxess Technologies, Micron Biomedical Inc., Kindeva Drug Delivery, Gurnet Point Capital, Moonlight Therapeutics Inc., Cutanos, Kimberly-Clark Corp., Clearside BioMedical Inc.
North America was the largest region in the microneedle drug delivery systems market in 2024. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the microneedle drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The microneedle drug delivery systems market consists of sales of hydrogel microneedles and dissolvable microneedle. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Microneedle Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on microneedle drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for microneedle drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microneedle drug delivery systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.